Loading...
Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Table of Content

    Volume 29 Issue 3
    26 March 2024
    UPLC-QE-MS combined network pharmacological analysis of the mechanism of ulcerative colitis
    SU Xin, LUO Lin
    2024, 29(3):  241-251.  doi:10.12092/j.issn.1009-2501.2024.03.001
    Asbtract ( 83 )   PDF (2710KB) ( 62 )  
    Related Articles | Metrics
    AIM:To explore the anti-ulcerative colitis mechanism of Buzhongyiqi pills based on the network pharmacology and experimental verification. METHODS: UPLC-QE-MS was used for qualitative analysis of Buzhongyiqi pills. Targets of the chemistry constituents and the disease were retrieved from GeneCards. Then the protein-protein interaction (PPI) network was constructed and core targets were screened for GO term enrichment and KEGG pathway enrichment.  Ulcerative colitis mouse model was established to verify the key targets. RESULTS: A total of 41 constituents migrating of Buzhongyiqi pills were identified. A total of 123 common targets of the constituents and the disease and 24 core targets were screened out.KEGG enrichment and PPI network analysis showed that Buzhongyiqi pills may play a role in the treatment of ulcerative colitis through Akt, PI3K and other pathways. Furthermore, the results of animal experiments showed that Buzhongyiqi pills could significantly improve the depression behaviors of ulcerative colitis, reduce the levels of IL-6 and TNF-α in serum, inhibition Akt/PI3K signaling, and reduce the protein expression of PI3K. CONCLUSION: Buzhongyiqi pills may play a role in the treatment of ulcerative colitis by inhibition Akt/PI3K signaling pathway, and inhibiting PI3K and reduce the levels of IL-6 and TNF-α in the mice.
    Transcriptomic analysis of the molecular mechanism of Tiaopi Chengqi decoction improving gastric digestive function in mice with food accumulation
    WANG Xiaoyun, ZHAO Huaizhou, TONG Liguo, JI Haijie, YANG Qian, WANG Ping, LU Haiyan, SONG Mingsuo
    2024, 29(3):  252-259.  doi:10.12092/j.issn.1009-2501.2024.03.002
    Asbtract ( 57 )   PDF (2578KB) ( 25 )  
    Related Articles | Metrics
    AIM:To explore the molecular mechanism of Tiaopi Chengqi decoction (TpCqD) improving hyperthermia and high-protein food-induced hyperphagia mice based on transcriptomics. METHODS:C57 mice were randomly divided into a control group,model group,low-dose TpCqD group, high-dose TpCqD group, and domperidone group. The general condition of the experimental mice was observed and the average food intake was counted, and the rate of gastric emptying and intestinal propulsion was determined for each group of mice. H&E staining was used to observe pathological changes in gastric tissue. PAS staining was used to observe glycogen changes in gastric tissue. Pepsin activity was determined by colorimetry. pH value of gastric contents was measured by acid-base titration. Transcriptome sequencing was used to analyze the differential genes in gastric tissue,a volcano map and a cluster heat map were made for the differential genes, and KEGG was used to analyze the signal pathway enrichment of the differential genes. RT-qPCR verified the differential genes obtained by screening. RESULTS:After treatment with TpCqD, the body weight and average food intake of mice with food accumulation increased (P<0.05), and the intestinal propulsion rate and gastric emptying speed of mice with food accumulation accelerated (P<0.05). TpCqD could protect gastric tissue structure and glycogen degradation, increase pepsin activity (P<0.05), and reduce gastric content pH (P<0.05). Transcriptome results showed that TpCqD could regulate the expression of Acox2 and cilp2, regulate fat digestion and absorption, protein digestion and absorption, and pancreatic secretion signals. RT-qPCR showed that compare with model group, TpCqD up-regulated Acox2 (P<0.05) and down-regulated the mRNA level of cilp2 (P<0.05). CONCLUSION:TpCqD ameliorated digestive dysfunction in mice with high-calorie and high-protein diets leading to food accumulation involving the regulation of the fat and sugar metabolism genes Acox2 and cilp2, and pancreatic secretory signaling.
    Mechanism of Dahuangtang pellets in regulating podocyte autophagy of diabetic nephropathy mice through AMPK/mTOR/ULK1 signaling pathway 
    SU Beibei, YANG Lixia, LIANG Yonglin, ZHU Xiangdong, YANG Xia, XUE Chunxia, ZHANG Pu, PEI Xiaoli
    2024, 29(3):  260-269.  doi:10.12092/j.issn.1009-2501.2024.03.003
    Asbtract ( 55 )   PDF (6320KB) ( 38 )  
    Related Articles | Metrics
    AIM: To explore the intervention effect of Dahuangtang pellets (DHT) on diabetic nephropathy (DN) based on the AMP-activated protein kinase/mammalian target of rapamycin/unc-51-like kinase 1 (AMPK/mTOR/ULK1) signaling pathway. METHODS: Eight mice were randomly assigned to the model group, the dapagliflozin group, and the DHT (high, medium, and low dosage) group out of a total of 40 C57BL/KSJ-db/db (hereafter referred to as db/db) mice; another 10 C57BL/KSJ-db/dm mice were used as the normal group, saline was provided to the normal and model groups, and the mice in the treatment group received the appropriate medications. The medications were given for 10 consecutive weeks, once per day, to the mice in the treatment group. At weeks 0, 4, 8, and 10 of administration, fasting blood glucose (FBG) was assessed by drawing blood at a predetermined time from the tail vein; Urine samples were taken at 0, 5, and 10 weeks after treatment to evaluate the levels of albumin and creatinine, and the urinary albumin-creatinine ratio (ACR) was computed. After 10 weeks, mice in each group were assayed for 24 h total urine protein, serum creatinine (Scr), urea nitrogen (BUN) levels; Western blotting analysis was conducted to detect the expression of p-AMPK, p-mTOR, and p-ULK1, as well as the expression of autophagy related proteins homolog of yeast Atg6 (Beclin-1), autophagy-related proteins microtubule-associated protein 1 light chain 3 (LC3), P62 in renal tissue; Immunohistochemistry was used to measure the expression of podocyte lacunar membrane proteins (Nephrin, Podocin) in renal tissues; The pathological morphology of renal tissue was observed by light microscopy and transmission electron microscopy. RESULTS: Compared with the model group, FBG, ACR, and 24 h total urine protein were reduced in the dapagliflozin group and DHT groups of mice, and there was no statistically significant difference in Scr and BUN; In renal tissues, there is increased expression of p-AMPK and p-ULK1, decreased expression of p-mTOR, increased expression of LC3II/LC3I and Beclin-1, and decreased expression of P62 (P<0.01, P<0.05); differentially upregulated in glomeruli are the podocyte lacunar membrane proteins Nephrin and Podocin (P<0.01, P<0.05); renal pathologic damage was reduced to varying degrees; transmission electron microscopy showed an increase in the number of autophagic vesicles and autophagic lysosomes. CONCLUSION: DHT can delay the development of DN by regulating the AMPK/mTOR/ULK1 signaling pathway, enhancing podocyte autophagy, and protecting glomeruli.
    Effects of the proliferation, migration and apoptosis of AHVAC-Ⅰ on gastric cancer MKN-28 cells
    HUANG Xiaomei, ZHI Hui, CHEN Hao, LU Linming, ZHU Xiaoqun, WANG Lizhen, ZHOU Jue, PANG Jinjin, XU Jinliang
    2024, 29(3):  270-276.  doi:10.12092/j.issn.1009-2501.2024.03.004
    Asbtract ( 42 )   PDF (1799KB) ( 25 )  
    Related Articles | Metrics
    AIM: To investigate the effects of agkis-trodon halys venom anti-tumor component Ⅰ (AHVAC-Ⅰ) on the biological behavior of gastric cancer MKN-28 cells. METHODS: Gastric cancer MKN-28 cells were treated with the experimental concentrations (5, 10, 15 μg/mL) of AHAVC-Ⅰ for 24 h.Cell proliferation and toxicity assay (cell counting kit-8, CCK-8) was used to detect the inhibition rates of the cells in different concentrations of AHVAC-Ⅰ. The migration ability of the cells was evaluated by wound-healing and Transwell assay. The apoptosis were observed by laser confocal microscopy with annexin V-mCherry/DAPI double staining, and the apoptosis rates were analyzed by flow cytometry with annexin V-FITC/PI double fluorescence staining. The protein level of Caspease-3 was determined by Western blot. RESULTS: Compared with normal control group, the results of AHVAC-Ⅰ concentration groups showed that with the increase of AHVAC-Ⅰ concentration, the proliferative activity of MN-28 cells decreased gradually (P<0.01), the cell migration ability decreased gradually (P<0.01), and the cell apoptosis rate increased (P<0.05). The expression of apoptosis-related protein Caspease-3 was up-regulated (P<0.01). CONCLUSION: AHVAC-Ⅰ inhibits proliferation and migration of gastric cancer MSN-28 cells and induces apoptosis.
    Effects of osthole on renal oxidative stress injury in aged spontaneously hypertensive rats by regulating PI3K/Akt/mTOR signaling pathway 
    YU Dan, LIU Zongtao, YAN Xiaohong, CHENG Jing, LI lin
    2024, 29(3):  277-282.  doi:10.12092/j.issn.1009-2501.2024.03.005
    Asbtract ( 48 )   PDF (1098KB) ( 22 )  
    Related Articles | Metrics
    AIM: To explore the mechanism of osthole on elderly spontaneously hypertensive rats. METHODS: 20-month-old spontaneously hypertensive rats (SHRs) and healthy Wistar-Kyoto (WKY) rats were purchased. SHRs were treated with osthole (i.g.) for 8 weeks. The systolic blood pressure and diastolic blood pressure of rats were monitored. Hematoxylin-eosin staining (H&E), periodic acid-schiff staining (PAS) and Masson staining were used to observe the pathological changes of rat kidney tissues. The activity of superoxide dismutase (SOD), malondialdehyde (MDA) and glutathione (GSH) in rat kidney was detected by ELISA kit. PI3K/Akt/mTOR signaling pathway related proteins were detected by western blot. RESULTS: Osthole reduced the systolic and diastolic blood pressure of SHRs, improved the histopathological changes of SHRs kidney, reduced the activity of MDA in SHRs kidney, and increased the activity of SOD and GSH. Osthole reduced the levels of p-PI3K, p-Akt and p-mTOR. CONCLUSION: Osthole reduces the activity of PI3K/Akt/mTOR signaling pathway and exerts a protective effect on renal oxidative stress injury in aged spontaneously hypertensive rats. 
    Construction of a column-line graph for predicting the probability of survival in early-stage elderly HER2-positive breast cancer based on the SEER database
    WU Guilan, LIU Jia, SUN Hong
    2024, 29(3):  283-295.  doi:10.12092/j.issn.1009-2501.2024.03.006
    Asbtract ( 42 )   PDF (1750KB) ( 18 )  
    Related Articles | Metrics
    AIM: To construct column-line plots to predict survival in elderly patients with early-stage HER2-positive breast cancer using the Surveillance, Epidemiology and End Results (SEER) database. METHODS: 5 220 (based on the era of single-targeted therapy) and 1 176 (based on the era of dual-targeted therapy) patients screened in the SEER database were randomized into a training group and an internal validation group. COX proportional risk regression was used to screen survival-related predictors and build a column-line graphical model, and the accuracy and utility of the model were tested using the consistency index (C-index), calibration curves, and time-dependent ROC curves. Patients receiving chemotherapy and non-chemotherapy were statistically paired using two-group propensity score matching, and subgroup analyses were performed on the screened variables. RESULTS: The single-targeted therapy era line graph was constructed from seven variables: age, marital status, T-stage, N-stage, surgery, chemotherapy, and radiotherapy. The dual-targeted therapy era line graph was constructed from five variables: age, AJCC staging, surgery, chemotherapy, and radiotherapy. The results of the subgroup analysis showed that older HER2-positive breast cancer patients who received chemotherapy had better OS. CONCLUSION: Based on the SEER database, an accurate column-line graph predicting survival in elderly patients with early-stage HER2-positive breast cancer was established and validated. This study suggests that chemotherapy increases survival benefit in elderly patients.
    Effects of the timing of satisfactory sedation with preoperative oral midazolam on anesthesia induction and recovery in children undergoing adenotonsillectomy
    BAI Yue, JIN Qiqi, CAI Weicha, LI Jianlin, ZHOU Yingfeng, YUAN Kaiming, LI Jun
    2024, 29(3):  296-302.  doi:10.12092/j.issn.1009-2501.2024.03.007
    Asbtract ( 54 )   PDF (733KB) ( 34 )  
    Related Articles | Metrics
    AIM: To investigate the effect of the timing of satisfactory sedation with preoperative oral midazolam on anesthesia induction and recovery in children undergoing adenotonsillectomy. METHODS: A total of 147 children undergoing elective adenotonsillectomy, with ASA physical status ⅠorⅡ, aged 2-7 years were selected from November 2022 to June 2023 in the Second Affiliated Hospital of Wenzhou Medical University. The children were orally administered 0.5 mg/kg midazolam in preoperative waiting area and were divided into 10-20 min (rapid onset, M1 group) and 21-30 min (slow onset, M2 group) based on the satisfactory sedation time, or equal volume of sugar pear drink orally (blank control group, C group). Children in all three groups received a general anesthesia method of propofol+fentanyl combined with sevoflurane induction and sevoflurane maintenance. The primary outcome measures were the induction compliance checklist (ICC) score and the pediatric anesthesia emergence delirium (PAED) score in the post-anesthesia care unit (PACU) to assess the occurrence of emergence agitation (EA), and the secondary outcome measures included the parental separation anxiety scale (PSAS), sedation Ramsay score, surgery duration, recovery time, PACU stay time, discharge time, the incidence of perioperative respiratory adverse events (PRAE) and other adverse events in the ward. RESULTS: 147 children were included in the result analysis, with 49 cases in each group. The proportion of perfect induction (ICC=0) were significantly higher in two M groups than that in group C (95.9% vs. 91.8% vs. 61.2%, P=0.001). The maximum and average PAED score in PACU in group M1 showed a significantly higher (6.4±5.0 vs. 4.4±4.1, P=0.029; 5.2±4.5 vs. 3.4±3.6, P=0.030), and the incidence of EA was significantly higher than those in  group C (10.2% vs. 30.6%, P=0.022), and increased compared to the group M2 (OR=0.581, 95%CI 0.231-1.463, P=0.354). There was no statistically significant difference in the maximum and average PAED scores, incidence of EA between group M2 and group C (P>0.05). The Ramsay score and PSAS score in two M groups were higher, PACU stay time and recovery time was longer than those in group C (P<0.05). The pain scores in PACU in group M1 was higher than that of group C (P<0.05). There was no statistically significant difference in the surgical time, discharge time, the incidence of PRAE and other adverse events in the ward among three groups (P>0.05). CONCLUSION: Preoperative oral midazolam can improve the ICC and PSAS scores of children during induction, but it also leads to prolonged recovery time and PACU retention time. The rapid onset of midazolam did not result in better induction and recovery quality, but instead increased the incidence of EA and postoperative pain score.
    Effects of low concentration atropine on macular microcirculation in children with different degrees of myopia
    GE Wei, SHENG Wenyan, XU Qibin, ZHU Liwei, LI Qiushi
    2024, 29(3):  303-309.  doi:10.12092/j.issn.1009-2501.2024.03.009
    Asbtract ( 65 )   PDF (628KB) ( 44 )  
    Related Articles | Metrics
    AIM: To investigate the effects of 0.01% atropine eye drops on macular blood flow density and retinal thickness in children with different degrees of myopia. METHODS: This was a prospective case-control study. Sixty-four patients (112 eyes) diagnosed with myopia for the first time with 0.01% atropine eye drops before and 6 months after medication were investigated with the uncorrected distance visual acuity (UCVA), axial length (AL), spherical equivalent (SE), macular ganglion cell-inner plexiform layer thicknes (mGCIPL) using slit lamp examination and optical coherence tomography (OCT), vascular density in the macular area and the area of the avascular in the fovea using optical coherence tomography angiography (OCTA) . Changes in various indicators before and after medication were compared. RESULTS: Compared with before medication, the AL of the three groups of myopia patients increased significantly (P<0.01), the difference in low to moderate myopia group was significantly smaller than that in high myopia group.Compared with before medication, SE increased in all three groups of myopia patients, yet there was no statistically significant difference in the low-grade myopia group (P>0.05). The difference was statistically significant between the moderate myopia group and the high myopia group (P<0.01). Compared with before medication, there was no change in intraocular?pressure (IOP) among the three groups of myopic patients (P>0.05). After 6 months of medication, the central circle macular vessel density (cCVD) increased in the low myopia group and moderate myopia group (P<0.01), there was no statistically significant difference in the high myopia group (P>0.05). Before and after medication, there was no significant difference in outer circle macular vessel density (oCVD), inner circle macular vessel density (iCVD), and whole circle macular vessel density (wCVD) among the three myopia groups (P>0.05). The increase in mGCIPL was statistically significant in the low myopia group (P<0.01), but there was no statistically significant difference in the moderate myopia and high myopia groups (P>0.05).There was no significant difference in foveal avascular zone (FAZ) among the three myopia groups before and after medication (P>0.05). There was no correlation between CVD, AL, and SE in the three myopia groups (P>0.01).There was a low correlation between CVD and mGCIPL in the low myopia group (r=0.442, P<0.05), there was no correlation between CVD and mGCIPL in the moderate myopia and high myopia groups (P>0.01). CONCLUSION: 0.01% atropine can significantly reduce the rate of axial and refractive growth in children with low to moderate myopia, increase the density of central macular vessels, and increase the thickness of mGCIPL in children with low to moderate myopia.
    Feasibility of remimazolam mimic propofol Marsh mode target-controlled infusion during anesthesia
    JIANG Yu, HOU Wenlong, ZONG Youming
    2024, 29(3):  310-315.  doi:10.12092/j.issn.1009-2501.2024.03.009
    Asbtract ( 14 )   PDF (635KB) ( 8 )  
    Related Articles | Metrics
    AIM: To evaluate the feasibility of Marsh target-controlled infusion of simulated propofol with remimazolam for induction and maintenance of anesthesia in patients undergoing laparoscopic gallbladder surgery. METHODS: A total of 80 patients undergoing elective laparoscopic gallbladder surgery were randomly divided into propofol group (Group P) and remimazolam group (Group R), with 40 cases in each group. Anesthesia was induced and maintained by target-controlled infusion of propofol and remimazolam respectively (Marsh mode, plasma target concentration). The time of loss of consciousness was recorded, and HR, MAP and BIS were induced before intubation (T0), immediately after intubation (T1), 3min after intubation (T2), immediately after pneumoperitoneum (T3), 30min during surgery (T4), and after surgery (T5). Injection pain, tracheal extubation time and postoperative adverse reactions were recorded. RESULTS: Compared with Group P, the loss of consciousness in Group R was shorter (P<0.05), the incidence of injection pain, intraoperative hypotension and bradycardia was lower (P<0.05), but the postoperative extubation time was longer (P<0.05). CONCLUSION: Remimazolam can be applied to the Marsh mode of propofol, and Remimazolam mimic target-controlled infusion (Marsh mode) has a good effect and safety on inducing and maintaining sedation under general anesthesia,as well as the vital signs are stable.
    The application of positron emission tomography in the research and development of central nervous system drugs
    LI Size, HUANG Qi, WU Xiaojie, WANG Shaonan, GUAN Yihui, XIE Fang, ZHANG Jing
    2024, 29(3):  316-327.  doi:10.12092/j.issn.1009-2501.2024.03.010
    Asbtract ( 46 )   PDF (1674KB) ( 39 )  
    Related Articles | Metrics
    Positron emission tomography (PET) now plays an important role in the research and development (R&D) of central nervous system (CNS) drugs. PET could characterize the biodistribution, pharmacokinetics, and receptor binding of CNS drugs quantitatively. The present review summarized the quantitative methods of PET used in the pharmacokinetics and receptor occupancy analysis of CNS drugs. Moreover, the present review listed various applications of PET supporting R&D of CNS drugs, which could provide a new direction for the R&D of CNS drugs.
    Pharmacological characteristics of esketamine and its application progress in pediatric anesthesia
    JIN Baowei, GUO Jianrong
    2024, 29(3):  328-333.  doi:10.12092/j.issn.1009-2501.2024.03.011
    Asbtract ( 54 )   PDF (545KB) ( 55 )  
    Related Articles | Metrics
    Esketamine is an antagonist of the N-methyl-D-aspartate (NMDA) receptor and exerts antianxiety, hypnotic, sedative, and analgesic effects by interacting with NMDA receptors, opioid receptors, M-choline receptors, monoamine receptors, adenosine receptors, and other purine receptors. As the more potents isomer of ketamine, it is about twice as potent as ketamine. Compared with ketamine, esketamine has the characteristics of rapid onset and metabolism, strong analgesia, slight respiratory depression, rapid recovery of cognitive function, and low incidence of psychiatric side effects. It has become a new choice of pediatric anesthesia drugs. This article reviews the pharmacological properties of esketamine and its recent application in pediatric anesthesia, and provides reference for the safe use of esketamine in pediatric perioperative period.
    Safety of G-CSF in patients with COVID-19
    LIU Heng, LI Zijian
    2024, 29(3):  334-338.  doi:10.12092/j.issn.1009-2501.2024.03.012
    Asbtract ( 31 )   PDF (522KB) ( 20 )  
    Related Articles | Metrics
    COVID-19, a disease caused by SARS-CoV-2 infection, has caused a global pandemic in a short time. The key immunopathological features of COVID-19 include lymphopenia, neutropenia, cytokine storm and related Immune damage to parenchymal organs such as lung. Granulocyte colony stimulating factor (G-CSF) can cause excessive inflammatory reaction, which may aggravate the condition of some patients. Therefore, it is controversial whether COVID-19 should be treated with G-CSF, and clinicians need to evaluate the effectiveness and safety of G-CSF according to the specific conditions of each patient.
    The attenuating and potentiating effects of traditional Chinese medicine in immune checkpoint therapy
    ZHANG Zhipeng, CHEN Ziqi, TIAN Jianhui
    2024, 29(3):  339-347.  doi:10.12092/j.issn.1009-2501.2024.03.013
    Asbtract ( 63 )   PDF (649KB) ( 54 )  
    Related Articles | Metrics
    Immunotherapy has become a global focus in cancer clinical practice and scientific research.In the past two years, PD-1\PD-L1 and CTLA-4 inhibitors, especially Nivolumab, Pembrolizumab, Atezolizumab and Lpilimumab, have been used in non-small cell lung cancer, colon cancer. Promising results have been obtained in malignancies such as melanoma and urinary tract cancer. Traditional Chinese medicine has a long history in China. Modulating immune checkpoints has certain advantages in treating malignant tumors, and it has shown good efficacy in improving its adverse events. This article reviews the role of traditional Chinese medicine in regulating immune checkpoints and improving adverse reactions and its application prospects in immunomodulatory treatment.
    Novel mechanisms driving renal tubulointerstitial fibrosis
    ZHANG Yanni, DUAN Yuxin, BAI Yi, YU Jinyao, SUN Jiayi, WANG Zejie, LI Ling, YE Qifa
    2024, 29(3):  348-353.  doi:10.12092/j.issn.1009-2501.2024.03.014
    Asbtract ( 66 )   PDF (1252KB) ( 24 )  
    Related Articles | Metrics
    Renal fibrosis, especially tubulointerstitial fibrosis, is the most common pathway of all chronic kidney diseases progressing to end-stage renal diseases. Several adaptive reactions occur in renal tubular epithelial cells after chronic injury, such as changes in glycolipid metabolism, unfolded protein response, autophagy and senescence, epithelial-to-mesenchymal transition and G2/M cell cycle arrest. Maladaptive repair mechanisms can induce tubulointerstitial fibrosis. This article will discuss the molecular mechanism of these adaptive responses of renal tubular epithelial cells driving renal tubulointerstitial fibrosis, and provide a basis for exploring new drug targets for renal tubulointerstitial fibrosis.
    Progress in researches for perampanel in the treatment of comorbidities of epilepsy
    CHEN Sirui, LI Junqiang, DANG Xiaoli, WANG Tiancheng
    2024, 29(3):  354-360.  doi:10.12092/j.issn.1009-2501.2024.03.015
    Asbtract ( 71 )   PDF (575KB) ( 53 )  
    Related Articles | Metrics
    Sleep disorder, migraine, cognitive and behavioral disorders, anxiety and depression are common comorbidities of epilepsy. The comorbidity rate of epilepsy patients is eight times that of the general population, which affects the prognosis and quality of life of epilepsy patients. Perampanel (PER), as a third-generation antiseizure medication, has shown promising clinical research and application in the treatment of comorbidities in epilepsy. PER can improve the total sleep time, sleep latency and sleep efficiency of patients with epilepsy comorbid sleep disorder. PER also shows good efficacy in reducing seizure and migraine attacks of patients with epilepsy comorbid migraine. Meanwhile, the impact of PER on overall cognitive characteristics is neutral, with no systematic cognitive deterioration or improvement, but behavioral changes are one of the most common adverse events related to PER. For patients with comorbid anxiety and depression, PER does not exacerbate the anxiety and depression of epilepsy patients, and the severity of anxiety and depression in some patients will improve. This article will review the mechanism of action and clinical treatment research progress of PER on comorbidities of epilepsy.